Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q0SRN4

Entry ID Method Resolution Chain Position Source
AF-Q0SRN4-F1 Predicted AlphaFoldDB

No variants for Q0SRN4

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q0SRN4

No associated diseases with Q0SRN4

No regional properties for Q0SRN4

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q0SRN4

Functions

Description
EC Number 2.4.99.17 Transferring other glycosyl groups
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

1 GO annotations of molecular function

Name Definition
S-adenosylmethionine:tRNA ribosyltransferase-isomerase activity Catalysis of the reaction: S-adenosylmethionine + 7-(aminomethyl)-7-deazaguanosine-tRNA = adenine + methionine + epoxyqueuosine-tRNA. 7-(aminomethyl)-7-deazaguanosine-tRNA is also known as preQ1-tRNA, and epoxyqueuosine-tRNA as oQ-tRNA.

1 GO annotations of biological process

Name Definition
queuosine biosynthetic process The chemical reactions and pathways resulting in the formation of queuosines, a series of nucleosides found in tRNA and having an additional pentenyl ring added via an NH group to the methyl group of 7-methylguanosine. The pentenyl ring may carry other substituents.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MKVSDFYFEL PEELIAQYPL EKRDSSRLMV LDKKTGEIEH RKFHDILEYL NEGDTLVLNN
70 80 90 100 110 120
TRVLPARLIG EKEETGGKIE FLLLKRIEGD KWECLAKPGR KAKVGTVFTF GEGKLKAIVR
130 140 150 160 170 180
EIGEEGNRII EFKYDGIFEQ VLDELGQMPL PPYIHEKLED KERYQTVYSK EKGSAAAPTA
190 200 210 220 230 240
GLHFTEDLLK EIKDKGVNIA YLTLHVGLGT FRPVKVDDVN NHVMHSEYYH LDKENAELIN
250 260 270 280 290 300
KTKEAGKRVI AVGTTSSRTL ETIGDENGRV REQSGWTDIF IYPGYKFKIV DNLITNFHLP
310 320 330 340
ESTLIMLVSA LAGQDNIMNA YNTAVKEKYR FFSFGDSMFI K